Discover 165 paid clinical trials in Tulsa, Oklahoma. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 165
Interoceptive Mechanisms of Body Image Disturbance in Anorexia Nervosa
for
Anorexia Nervosa, Body Image Disturbance, Interoception
Location: Tulsa OK
Sponsor: Laureate Institute for Brain Research, Inc.
Sex: Female
Age: 13 - 50
Code: NCT06332963
Recruiting
Evaluation of a Keto-Like Supplement on Brain Responses to Emotional Stimuli in Depression
for
Depression
Location: Tulsa OK
Sponsor: Laureate Institute for Brain Research, Inc.
Sex: All
Age: 18 - 65
Code: NCT06263660
Phase2, Recruiting
Ultrasound Neuromodulation of Circuits and Negative Valence Systems in Treatment-Resistant Depression
for
Treatment-Resistant Depression
Location: Tulsa OK
Sponsor: Laureate Institute for Brain Research, Inc.
Sex: All
Age: 18 - 65
Code: NCT07166289
Recruiting
Amplification of Positivity for Alcohol Use
for
Alcohol Use Disorder, Anxiety, Depression
Location: Tulsa OK
Sponsor: Laureate Institute for Brain Research, Inc.
Sex: All
Age: 18 - 65
Code: NCT06030154
Recruiting
Floatation-REST in Methamphetamine Use Disorder: A Pilot Study
for
Amphetamine-Type Substance Use Disorder
Location: Tulsa OK
Sponsor: Laureate Institute for Brain Research, Inc.
Sex: All
Age: 18 - 55
Code: NCT05799209
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
New
Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis
for
Lewy Body Dementia Psychosis
Location: Tulsa OK, Kansas City KS, Cypress TX, Stafford TX,
Sponsor: ACADIA Pharmaceuticals Inc.
Sex: All
Age: 55 - 70+
Code: NCT07095465
Phase3, Recruiting
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
for
Parkinson Disease
Location: Tulsa OK, Kansas City KS, Dallas TX, Little Rock AR,
Sponsor: Impax Laboratories, LLC
Sex: All
Age: 18+
Code: NCT06765668
Recruiting
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease